We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELTA.L Regulatory News (ELTA)

  • There is currently no data for ELTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Electra Private Equity plc

12 Jun 2018 15:20

RNS Number : 1464R
BlackRock Group
12 June 2018
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

BlackRock, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Electra Private Equity plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

11 June 2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

25p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

564,021

 

1.47%

0

0.00%

(2) Cash-settled derivatives:

 

207,492

0.54%

0

0.00%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00%

0

0.00%

 

TOTAL:

772,263

2.01%

0

0.00%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

25p ordinary

Sale

1,250

GBP 9.4000

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

Date of disclosure:

12 June 2018

Contact name:

James Michael

Telephone number:

+44 20 7743 3650

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETFKBDKNBKDFAD
Date   Source Headline
16th Nov 20169:46 amRNSHolding(s) in Company
8th Nov 20167:00 amRNSPROPOSED RETURN OF UP TO £200M TO SHAREHOLDERS
14th Oct 20167:00 amRNSResult of Strategic Review - Phase I
7th Oct 20167:05 amRNSElectra Partners announces the sale of Vidal Group
4th Oct 20167:10 amRNSPartial realisation of Premier Asset Management
23rd Sep 201611:37 amRNSElectra Partners completes the sale of Elian
16th Sep 20167:08 amRNSElectra Private Equity Hollywood IPO Release
1st Sep 20165:34 pmRNSHolding(s) in Company
16th Aug 20164:14 pmRNSHolding(s) in Company
3rd Aug 20163:55 pmRNSDirector/PDMR Shareholding
3rd Aug 20163:53 pmRNSDirector/PDMR Shareholding
27th Jul 20165:23 pmRNSDirector/PDMR Shareholding
22nd Jul 20167:00 amRNSAppointment of Chief Financial Officer
19th Jul 20163:43 pmRNSDirector/PDMR Shareholding
19th Jul 201611:37 amRNSDirector/PDMR Shareholding
1st Jul 20167:00 amRNSPartial realisation of Allflex
28th Jun 20164:45 pmRNSDirector Declaration
20th Jun 20167:00 amRNSDirectorate Change
17th Jun 20164:21 pmRNSHalf-year Report
14th Jun 20167:00 amRNSCancellation of Revolving Credit Facility
6th Jun 20169:31 amRNSDirector/PDMR Shareholding
6th Jun 20167:21 amRNSElectra Partners agrees sale of Elian
2nd Jun 20163:56 pmRNSDirectorate Change
2nd Jun 20169:30 amRNSAdditional Information re Board Appointments
27th May 20169:46 amRNSDirector/PDMR Shareholding
26th May 20167:00 amRNSInterim Update on Strategic Review
4th May 20167:00 amRNSHalf-year Report
19th Apr 20167:00 amRNSDirectorate Change
4th Apr 201612:06 pmRNSDirector/PDMR Shareholding
16th Mar 20169:48 amRNSDirector/PDMR Shareholding
1st Mar 20165:47 pmRNSDirector/PDMR Shareholding
25th Feb 20166:30 pmRNSDisclosure of home member state
25th Feb 20167:00 amRNSChange of broker
10th Feb 201612:13 pmRNSDirector/PDMR Shareholding
4th Feb 20169:29 amRNSDirector/PDMR Shareholding
4th Feb 20167:00 amRNSElectra announces the sale of Daler-Rowney
29th Jan 201611:11 amRNSDirector/PDMR Shareholding
28th Jan 20167:00 amRNSQuarterly Update Report
26th Jan 20164:53 pmRNSHolding(s) in Company
26th Jan 201612:20 pmRNSSpecial Resolution passed at AGM - 25 January 2016
26th Jan 20167:00 amRNSResult of AGM
25th Jan 20167:00 amRNSBoard review of investment policy and structure
12th Jan 20161:56 pmRNSDirector/PDMR Shareholding
8th Jan 20162:34 pmRNSHolding(s) in Company
6th Jan 201610:27 amRNSDirector/PDMR Shareholding
4th Jan 201610:15 amRNSTotal Voting Rights
4th Jan 20169:57 amRNSHolding(s) in Company
31st Dec 201510:17 amRNSBlocklisting Interim Review
30th Dec 20153:40 pmRNSMandatory Conversion of Bonds clarification
30th Dec 201510:20 amRNSMandatory Conversion of Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.